Amendment No. 2 to Ocular Therapeutix, Inc. 2019 Inducement Stock Incentive Plan
Ocular Therapeutix, Inc. has amended its 2019 Inducement Stock Incentive Plan to increase the number of shares available for awards to 3,804,000 shares of common stock. This amendment was approved by the company's Board of Directors on February 20, 2024. The plan governs how stock incentives are granted to eligible individuals, and this change updates the total shares that may be issued under the plan.
Exhibit 10.5
OCULAR THERAPEUTIX, INC.
Amendment No. 2 to 2019 Inducement Stock Incentive Plan
Ocular Therapeutix, Inc’s 2019 Inducement Stock Incentive Plan (the “Plan”), pursuant to Section 11(d) thereof, is hereby amended as set forth below.
The first sentence of Section 4(a) of the Plan be, and hereby is, deleted in its entirety and replaced with the following in lieu thereof:
“Subject to adjustment under Section 9, Awards may be made under the Plan for up to 3,804,000 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”).”
Adopted by the Board of Directors: February 20, 2024
